We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$199M
AUM Growth
+$6.89M
Cap. Flow
+$1.95M
Cap. Flow %
0.98%
Top 10 Hldgs %
38.15%
Holding
110
New
9
Increased
22
Reduced
38
Closed
4

Top Buys

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$2.66M
2
VALE icon
Vale
VALE
+$944K
3
SH icon
ProShares Short S&P500
SH
+$897K
4
VMW
VMware, Inc
VMW
+$354K
5
T icon
AT&T
T
+$266K

Top Sells

Rank Stock Value
1
KL
Kirkland Lake Gold Ltd Ordinary
KL
+$2.22M
2
PG icon
Procter & Gamble
PG
+$676K
3
ABBV icon
AbbVie
ABBV
+$603K
4
LLY icon
Eli Lilly
LLY
+$432K
5
TGT icon
Target
TGT
+$276K

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.59%
2 Materials 17.44%
3 Healthcare 11.64%
4 Technology 8.3%
5 Industrials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
26
Copart
CPRT
$27.2B
$2.45M 1.23%
78,000
-1,900
-2% -$60.3K
INTC icon
27
Intel
INTC
$509B
$2.37M 1.19%
47,830
+1,350
+3% +$66.9K
LLY icon
28
Eli Lilly
LLY
$995B
$2.34M 1.18%
8,181
-1,678
-17% -$432K
AUY
29
DELISTED
Yamana Gold, Inc.
AUY
$2.31M 1.16%
413,820
+19,125
+5% +$90.4K
ESS icon
30
Essex Property Trust
ESS
$18.4B
$2.17M 1.09%
6,280
-100
-2% -$33.4K
MINT icon
31
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$2.15M 1.08%
21,500
GRX
32
Gabelli Healthcare & Wellness Trust
GRX
$143M
$2.15M 1.08%
167,400
PEP icon
33
PepsiCo
PEP
$190B
$2.05M 1.03%
12,223
-262
-2% -$44K
CLX icon
34
Clorox
CLX
$12.7B
$1.96M 0.99%
14,110
-200
-1% -$30.6K
VZ icon
35
Verizon
VZ
$195B
$1.95M 0.98%
38,323
+1,500
+4% +$79.5K
BMY icon
36
Bristol-Myers Squibb
BMY
$135B
$1.9M 0.95%
26,006
-62
-0.2% -$4.16K
SO icon
37
Southern Company
SO
$107B
$1.89M 0.95%
26,066
VMW
38
DELISTED
VMware, Inc
VMW
$1.82M 0.92%
16,025
+2,925
+22% +$354K
HE icon
39
Hawaiian Electric Industries
HE
$2.19B
$1.77M 0.89%
41,832
-400
-0.9% -$16.7K
ABT icon
40
Abbott
ABT
$185B
$1.71M 0.86%
14,441
-500
-3% -$62K
NUE icon
41
Nucor
NUE
$59.5B
$1.69M 0.85%
11,350
+600
+6% +$73.6K
AAPL icon
42
Apple
AAPL
$4.52T
$1.64M 0.82%
9,380
-450
-5% -$75.7K
VTR icon
43
Ventas
VTR
$46.6B
$1.6M 0.8%
25,944
WPC icon
44
W.P. Carey
WPC
$16.6B
$1.55M 0.78%
19,603
OXY icon
45
Occidental Petroleum
OXY
$54.8B
$1.54M 0.78%
27,207
-600
-2% -$26.5K
T icon
46
AT&T
T
$160B
$1.45M 0.73%
80,994
+14,370
+22% +$266K
COP icon
47
ConocoPhillips
COP
$145B
$1.42M 0.71%
14,166
-12
-0.1% -$1.1K
SCHP icon
48
Schwab US TIPS ETF
SCHP
$16.3B
$1.41M 0.71%
46,380
SPDN icon
49
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$223M
$1.39M 0.7%
95,700
+13,450
+16% +$201K
JNJ icon
50
Johnson & Johnson
JNJ
$613B
$1.39M 0.7%
7,851
+602
+8% +$102K

Similar funds

Bennicas & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Bennicas & Associates held 110 positions worth $199M, up 3.6% from $192M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Bennicas & Associates's Q1 2022 filing shows 9 new, 22 increased, 38 reduced and 4 closed positions. Its largest new stake was Vale: 54,500 shares worth $1.09M. The largest sale was Kirkland Lake Gold Ltd Ordinary, an estimated $2.22M.

By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, down from 21% a quarter earlier, followed by Materials and Healthcare.

  • Bennicas & Associates's largest Q1 2022 buy was Vale: 54,500 shares worth $1.09M.
  • Bennicas & Associates added most to Agnico Eagle Mines in Q1 2022, an estimated $2.66M increase.
  • Bennicas & Associates's biggest Q1 2022 reduction was Procter & Gamble, cutting an estimated $676K.
  • Bennicas & Associates fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $2.22M.
  • Bennicas & Associates's ten largest holdings make up 38% of its $199M portfolio in Q1 2022.
  • Bennicas & Associates opened 9 new positions and closed 4 in Q1 2022.
  • Bennicas & Associates's portfolio value rose 3.6% quarter-over-quarter to $199M.

Based on Bennicas & Associates's 13F filing for Q1 2022, filed 15 Apr 2022.